Tradestie Institutional Equity Comparison Engine

EQ vs MTNB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EQ Overall Edge

EQ Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Equillium, Inc. Common Stock (EQ) driven by superior Valuation, Growth & Margin, Options & Structure while MTNB counters with relative strength in Momentum & Technical. Fundamentally, EQ trades at 1.5x Forward P/E with 0.0% operating margin (-52.3% YoY revenue) versus MTNB at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, EQ sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against MTNB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner EQ
EQ 1.5x vs MTNB N/M Fwd P/E
Growth & Margin Winner EQ
Op Margin 0.0% vs 0.0% ยท YoY -52.3% vs -100.0%
Momentum & Technical Winner MTNB
1Y +12.0% vs -31.4% ยท 52W Pos 11% vs 22%
Options & Structure Winner EQ
UNCLASSIFIED (100th %ile IV) vs UNCLASSIFIED (N/A IV)
EQ NASDAQ
Equillium, Inc. Common Stock
Pharmaceutical Preparations
$1.12
+1.82% 1D
Market Cap $90.6M
1M Return -21.13%
1Y Return +12.0%
Forward P/E 1.5x
Unified AI Score
48.0 / 100 HOLD
Tech 30.0 Fund 51.0 Flow 63.0 Mom 60.0
MTNB NYSE American
Matinas BioPharma Holdings, Inc.
Pharmaceutical Preparations
$0.81
-10.98% 1D
Market Cap $979,904
1M Return -46.7%
1Y Return -31.35%
Forward P/E N/M
Unified AI Score
54.6 / 100 HOLD
Tech 53.0 Fund 58.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EQ +12.0% MTNB -31.35% Spread: +43.35 pp (EQ Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period EQ Revenue MTNB Revenue EQ Op. Margin MTNB Op. Margin Margin Edge
FY2017 N/A $0M N/A -11024.6% MTNB
FY2018 N/A $0M N/A -12230.9% MTNB
FY2019 N/A $0M N/A -21067.4% MTNB
FY2020 N/A $0M N/A -15288.4% MTNB
FY2021 N/A $0M N/A -74954.5% MTNB
FY2022 $20M $0M -393.9% -771.3% EQ
FY2023 $40M $0M -40.2% -2168.4% EQ
FY2024 $40M N/A -20.1% N/A EQ

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EQ (6) vs MTNB (2)
Institutional Metric EQ MTNB Criterion Row Winner
Market Capitalization Scale $90.6M $979,904 Larger Scale EQ
Trailing P/E Ratio Valuation 1.5x N/M Lower Multiple EQ
Forward P/E Ratio Valuation 1.5x N/M Lower Multiple EQ
Revenue Growth (YoY) Growth -52.3% -100.0% Higher Growth EQ
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -59.0% -147.5% Higher ROE EQ
52-Week Range Position Momentum 11% ($1โ€“$4) 22% ($0โ€“$3) Stronger Trend MTNB
Beta / 30D Volatility Risk Regime 1.53ฮฒ ยท 93% Vol -7.20ฮฒ ยท 147% Vol Lower Realized Risk EQ
Unified Institutional Score Composite Signal 48.0 / 100 (HOLD) 54.6 / 100 (HOLD) Higher Composite MTNB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EQ vs MTNB Buy Guide
EQ UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live EQ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MTNB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MTNB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EQ nor MTNB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.